Evidence map›Paper›PMID 26947936›Full record

ArticleProtein science : a publication of the Protein Society2016

Spa47 is an oligomerization-activated type three secretion system (T3SS) ATPase from Shigella flexneri.

Jamie L Burgess, Heather B Jones, Prashant Kumar, Ronald T Toth, C Russell Middaugh, Edwin Antony, Nicholas E Dickenson

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Differential regulation ofFrontiers in cellular and infection microbiology · 2023
    Article
  4. Assembly and architecture of the type III secretion sorting platform.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. TheMicroorganisms · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jamie L BurgessDepartment of Chemistry and Biochemistry, Utah State University, Logan, Utah, 84322.
Heather B JonesDepartment of Chemistry and Biochemistry, Utah State University, Logan, Utah, 84322.
Prashant KumarDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas, 66047.
Ronald T TothDepartment of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas, 66047.
C Russell MiddaughDepartment of Pharmaceutical Chemistry, Macromolecule and Vaccine Stabilization Center, University of Kansas, Lawrence, Kansas, 66047.
Edwin AntonyDepartment of Biological Sciences, Marquette University, Milwaukee, Wisconsin, 53201.
Nicholas E DickensonDepartment of Chemistry and Biochemistry, Utah State University, Logan, Utah, 84322.
University of Kansas · USUtah State University · USMarquette University · US

Funding

Fluorescent probes to monitor Rad51 nucleoprotein dynamicsR15GM110671 · NIGMS · UTAH STATE UNIVERSITY · PI ANTONY, EDWIN · 2015 to 2015
$346k
NIGMS NIH HHS R15 GM110671NIGMS NIH HHS R15GM110671
6 · The paper itself

Abstract

Gram-negative pathogens often use conserved type three secretion systems (T3SS) for virulence. The Shigella type three secretion apparatus (T3SA) penetrates the host cell membrane and provides a unidirectional conduit for injection of effectors into host cells. The protein Spa47 localizes to the base of the apparatus and is speculated to be an ATPase that provides the energy for T3SA formation and secretion. Here, we developed an expression and purification protocol, producing active Spa47 and providing the first direct evidence that Spa47 is a bona fide ATPase. Additionally, size exclusion chromatography and analytical ultracentrifugation identified multiple oligomeric species of Spa47 with the largest greater than 8 fold more active for ATP hydrolysis than the monomer. An ATPase inactive Spa47 point mutant was then engineered by targeting a conserved Lysine within the predicted Walker A motif of Spa47. Interestingly, the mutant maintained a similar oligomerization pattern as active Spa47, but was unable to restore invasion phenotype when used to complement a spa47 null S. flexneri strain. Together, these results identify Spa47 as a Shigella T3SS ATPase and suggest that its activity is linked to oligomerization, perhaps as a regulatory mechanism as seen in some related pathogens. Additionally, Spa47 catalyzed ATP hydrolysis appears to be essential for host cell invasion, providing a strong platform for additional studies dissecting its role in virulence and providing an attractive target for anti-infective agents.

Indexed as

Adenosine TriphosphatasesCatalytic DomainChromatography, GelHeLa CellsHumansPoint MutationProtein MultimerizationShigella flexneriType III Secretion SystemsAdenosine TriphosphatasesSpa47 protein, Shigella flexneriType III Secretion SystemsADPATPATPaseoligomerizationprotein exporttype III secretion system (T3SS)virulence factor

Identifiers

PMID26947936
PMCPMC4838647
OpenAlexW2296284289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.